Healthcare is one of the most complex and high-value segments of European public procurement. As the European Commission's health procurement data shows, hospitals, regional health systems, and national health services collectively spend tens of billions of euros annually on medical devices, pharmaceuticals, diagnostic equipment, health IT systems, and clinical services. Suppliers of medical devices must comply with the EU Medical Devices Regulation (MDR 2017/745). The sector sits at the intersection of public procurement law, medical device regulation, pharmaceutical policy, and patient safety requirements — creating a market that is demanding to enter but enormously rewarding for qualified suppliers.
This guide covers how healthcare procurement works in the EU, where to find opportunities, which markets matter most, and how suppliers can position themselves to build a repeatable public-sector pipeline in this critical sector.
Sector overview: healthcare procurement by the numbers
EU member states spend approximately 8-11% of GDP on healthcare, with a substantial portion flowing through public procurement channels. The total addressable market for healthcare procurement in Europe is estimated at 200+ billion EUR annually, encompassing:
- Medical devices and equipment (CPV 33) — Imaging systems (MRI, CT, X-ray), surgical instruments, monitoring equipment, implants, prosthetics, and disposables. This segment ranges from commodity consumables to multi-million-euro capital equipment.
- Pharmaceutical products — Hospital pharmaceuticals, vaccines, blood products, and specialty medicines. Increasingly procured through centralized frameworks.
- Health services (CPV 85) — Outsourced clinical services, ambulance services, laboratory testing, occupational health, mental health services, and rehabilitation.
- Health IT — Electronic health records (EHR), hospital information systems, telemedicine platforms, and health data analytics.
- Facility and support services — Hospital catering, cleaning, laundry, waste management, and facilities maintenance.
The buyer landscape is shaped by each country's health system model. In national health service systems (UK, Nordic countries, Italy, Spain), procurement is often centralized or semi-centralized. In social insurance systems (Germany, France, Netherlands), hospitals may be independent buyers with their own procurement departments. University hospitals, military health services, and prison health services add further buyer categories.
How healthcare procurement works
Healthcare procurement operates within the EU procurement framework but with sector-specific characteristics driven by patient safety, clinical requirements, and regulatory complexity.
Centralized versus decentralized purchasing
The trend across Europe is toward greater centralization of healthcare procurement, driven by the desire to achieve economies of scale, standardize quality, and improve supply chain resilience:
- National purchasing bodies — NHS Supply Chain (UK), Resah (France), Consip health frameworks (Italy), and SKI (Denmark) manage large-volume framework agreements for medical supplies
- Hospital group purchasing — Groups of hospitals form purchasing consortia to aggregate demand
- EU Joint Procurement — The EU Joint Procurement Agreement (JPA), established after the H1N1 pandemic and expanded during COVID-19, enables member states to jointly procure medical countermeasures (vaccines, therapeutics, PPE)
- Individual hospital procurement — For specialized equipment and services, individual hospitals still run their own procurement procedures
Evaluation criteria specific to healthcare
Healthcare procurement evaluations go well beyond price. Typical criteria include:
- Clinical effectiveness — Evidence of patient outcomes, clinical trial data, and comparative effectiveness
- Total cost of ownership — Acquisition price, consumables, maintenance, training, and disposal costs
- Compatibility and integration — Interoperability with existing systems and equipment
- Service and support — Response times, on-site support availability, training programs, and spare parts management
- Innovation and technology roadmap — Future development plans and upgrade paths
- Sustainability — Environmental impact, packaging waste, energy consumption, and circular economy compliance
Regulatory requirements
Healthcare procurement is uniquely constrained by product regulation:
- Medical devices must carry CE marking under the EU Medical Devices Regulation (MDR 2017/745) — a rigorous process involving conformity assessment, clinical evaluation, and Notified Body certification
- In vitro diagnostics fall under IVDR 2017/746 with similar requirements
- Pharmaceuticals require marketing authorization from the EMA (centralized) or national competent authorities
- Health services are subject to professional licensing and accreditation requirements
These regulatory prerequisites are hard barriers to market entry — you cannot bid on medical device tenders without CE marking, regardless of how competitive your price or technology might be.
CPV codes for healthcare procurement
| CPV Division | Description | Typical contracts |
|---|---|---|
| 33 — Medical equipment | Devices, instruments, consumables | Imaging systems, surgical tools, PPE, implants |
| 85 — Health services | Clinical and care services | Laboratory testing, ambulance, rehabilitation |
| 38 — Laboratory equipment | Scientific instruments | Analyzers, microscopes, lab automation |
| 24 — Chemical products | Reagents and chemicals | Diagnostic reagents, laboratory chemicals |
| 35 — Safety and PPE | Protective equipment | Gloves, gowns, masks, safety equipment |
Where to find healthcare procurement opportunities
EU-level sources
- TED (Tenders Electronic Daily) — All above-threshold healthcare tenders from EU member states. Filter by CPV 33/85/38 for healthcare-specific opportunities.
- EU Joint Procurement — Published through DG SANTE when member states activate joint procurement mechanisms.
- EU Health Programme — Funds innovation procurement and pre-commercial procurement in health technology.
National platforms
Healthcare procurement appears on both general procurement platforms and health-specific channels:
- Germany: bund.de, state procurement platforms, and individual university hospital tenders. Germany's hospital procurement is highly decentralized, with approximately 1,900 hospitals each managing their own purchasing. See our German procurement market guide for full details.
- France: BOAMP, PLACE, Resah frameworks, and hospital group (GHT) tenders. France has consolidated procurement through 136 Groupements Hospitaliers de Territoire. See our French procurement market guide for full details.
- Italy: Consip health frameworks and regional health agency (ASL) tenders
- Netherlands: TenderNed and individual hospital/UMC tenders
- Nordic countries: national procurement portals and centralized health purchasing bodies
Health industry networks
- MedTech Europe and national medical device industry associations publish procurement forecasts
- Hospital purchasing consortium announcements
- National health service capital investment plans
- EU Health Union policy documents signaling future procurement priorities
Procurement intelligence
Healthcare procurement is fragmented across hundreds of buyers and platforms. Duke aggregates healthcare tenders from across the EU procurement landscape, enabling suppliers to monitor opportunities by product category, geography, buyer type, and contract value — ensuring comprehensive market coverage.
Key countries for healthcare procurement
Germany
Germany has the largest healthcare procurement market in the EU, driven by approximately 1,900 hospitals (including 34 university hospitals), a well-funded social insurance system, and significant investment in health infrastructure modernization. The Hospital Future Act (Krankenhauszukunftsgesetz — KHZG) allocated 4.3 billion EUR for hospital digitization, creating substantial demand for health IT and digital infrastructure.
France
France's healthcare procurement is increasingly centralized through Resah (the national health purchasing central) and the 136 GHTs (Groupements Hospitaliers de Territoire). The country has strong pharmaceutical procurement through the CEPS (Comite Economique des Produits de Sante) and is investing heavily in health data infrastructure (Health Data Hub) and telemedicine.
Nordic countries
The Nordic countries are global leaders in health technology adoption and digital health. Procurement is well-organized, transparent, and typically conducted in English for larger tenders. Denmark, Sweden, and Finland have sophisticated central purchasing bodies that run multi-year health frameworks covering everything from consumables to capital equipment.
Italy
Italy procures healthcare through Consip (national) and regional health agencies. The National Recovery and Resilience Plan (PNRR) is funding major investments in territorial health infrastructure, telemedicine, and medical equipment, creating a wave of procurement opportunities through 2026 and beyond.
Spain
Spain's 17 autonomous communities each manage their own health procurement, creating both complexity and opportunity. INGESA coordinates national-level procurement, while SERMAS (Madrid) and SCS (Catalonia) are among the largest regional buyers.
Winning strategies for healthcare procurement
Ensure regulatory readiness
Regulatory compliance is not negotiable in healthcare procurement. Before pursuing opportunities:
- Complete CE marking (MDR/IVDR) for all medical devices you plan to sell
- Establish quality management systems compliant with ISO 13485
- Obtain necessary national registrations and notifications
- Prepare clinical evaluation reports and post-market surveillance documentation
- Build relationships with Notified Bodies for ongoing conformity assessment
Understand total cost of ownership
Healthcare buyers increasingly evaluate bids on total cost of ownership (TCO) rather than acquisition price alone. Structure your proposals to highlight:
- Lower consumable costs per procedure or per test
- Longer equipment lifecycle and upgrade paths
- Reduced maintenance and downtime costs
- Training efficiency and user adoption
- Energy efficiency and sustainability benefits
Invest in clinical evidence
For medical devices and health technology, clinical evidence is a powerful differentiator. Invest in:
- Clinical studies demonstrating patient outcomes
- Real-world evidence from existing installations
- Comparative effectiveness data versus competing products
- Health economic analyses showing cost-effectiveness
- Published clinical papers and conference presentations
Build service infrastructure
Healthcare buyers need confidence that equipment will be supported throughout its lifecycle. Demonstrate:
- Local service engineer coverage with defined response times
- Spare parts availability and logistics
- Comprehensive training programs for clinical staff
- Remote monitoring and predictive maintenance capabilities
- Application support and clinical workflow optimization
Leverage innovation procurement
The EU and member states are increasing use of innovation procurement mechanisms — Pre-Commercial Procurement (PCP) and Public Procurement of Innovative Solutions (PPI) — in healthcare. These programs specifically seek novel solutions and can provide:
- Funding for R&D and prototyping phases
- Reference customers for new health technologies
- Faster market access compared to traditional procurement
- Collaboration with leading clinical institutions
Trends and outlook
Post-COVID supply chain resilience
The pandemic permanently changed healthcare procurement strategy. EU member states are now investing in:
- Strategic stockpiles of critical medical supplies (PPE, ventilators, pharmaceuticals)
- Domestic and European manufacturing capacity for essential health products
- Supply chain diversification away from single-source dependencies
- Real-time supply chain visibility and demand forecasting
Digital health acceleration
Telemedicine, remote monitoring, AI-assisted diagnostics, and electronic health records are being procured at unprecedented scale. The EU's European Health Data Space (EHDS) regulation is creating demand for interoperable health IT systems and data infrastructure.
Personalized medicine and diagnostics
Point-of-care diagnostics, companion diagnostics, and personalized treatment technologies are emerging procurement categories that require new evaluation frameworks and closer collaboration between clinical users and procurement teams.
Value-based procurement
A fundamental shift is underway from volume-based to value-based healthcare procurement. Buyers are structuring contracts around patient outcomes rather than unit prices — paying for successful treatments rather than individual products. This trend favors suppliers who can demonstrate measurable clinical value.
Sustainability in healthcare procurement
Hospitals are significant consumers of energy, water, and materials. Green public procurement criteria for healthcare are driving demand for sustainable medical devices (recyclable packaging, reprocessable instruments), energy-efficient equipment, and reduced-emission supply chains.
How Duke helps healthcare suppliers
Duke provides specialized procurement intelligence for the healthcare sector:
- Comprehensive monitoring of healthcare tenders (CPV 33, 85, 38) across 40+ countries, covering national platforms, hospital purchasing groups, and centralized frameworks
- Product-specific filtering allowing suppliers to track tenders by device category, clinical specialty, or service type
- Buyer intelligence showing hospital purchasing patterns, framework participation, and historical spend
- Market analytics revealing which countries and regions are investing most in specific health technology categories
- Early signals through Prior Information Notice monitoring and investment plan tracking across the European procurement market
Conclusion
Healthcare procurement in the EU is a demanding but high-value market. The combination of stringent regulatory requirements, complex evaluation criteria, and post-pandemic investment in health system resilience creates both barriers and opportunities. Suppliers who invest in regulatory compliance, clinical evidence, service infrastructure, and total cost of ownership capabilities are well-positioned to build lasting relationships with European health system buyers.
The market is evolving rapidly — digital health, value-based procurement, and supply chain resilience are reshaping how healthcare is bought and sold. Staying ahead of these trends, and monitoring opportunities systematically across Europe's fragmented healthcare procurement landscape, is essential for sustained success.
Related Resources
- Healthcare sector overview -- explore healthcare procurement opportunities on Duke
- European Procurement Market Size 2026 -- understand the full EU market context
- How to Navigate Framework Agreements -- essential for centralized health purchasing
- How to Evaluate Whether to Bid on a Government Contract -- bid/no-bid framework for complex healthcare tenders
- What Are CPV Codes? -- master the classification system for healthcare procurement
Ready to find procurement opportunities? Start your free trial or explore our procurement intelligence platform to stay ahead of the competition.